NASDAQ · Biotechnology

Tarsus Pharmaceuticals Inc (TARS)

$73.01 -6.00%
54 In band Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$67.79+7.70%

Company profile

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

SectorHealthcare
IndustryBiotechnology
Market cap$3.78B
P/E ratioNone
EPS$-15.86
Beta0.331
Dividend yield0.00%
52-week high$91.53
52-week low$53.89

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for TARS

An email when TARS closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 5:04 AM EST